BioDelivery Sciences International Inc (BDSI) - 500 Beiträge pro Seite
eröffnet am 16.09.03 14:12:21 von
neuester Beitrag 17.09.03 14:49:07 von
neuester Beitrag 17.09.03 14:49:07 von
Beiträge: 2
ID: 776.293
ID: 776.293
Aufrufe heute: 0
Gesamt: 721
Gesamt: 721
Aktive User: 0
ISIN: US09060J1060 · WKN: 766464
16,460
USD
-0,54 %
-0,090 USD
Letzter Kurs 02.04.22 NYSE
Neuigkeiten
Werte aus der Branche Biotechnologie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 8,7300 | +197,44 | |
| 5,5000 | +45,89 | |
| 1,7500 | +34,62 | |
| 0,8356 | +27,22 | |
| 1,4680 | +24,41 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,6620 | -17,66 | |
| 9,6000 | -18,64 | |
| 1,9300 | -26,27 | |
| 2,0400 | -58,87 | |
| 3,1600 | -60,35 |
Feedback
DonPenny.com has taken a position
in Biodelivery SciencesInternational Inc. NASDAQ (BDSI) based on the recent successes of Nanotechnology companies (FLML, NANX, NVEC, TINY). BDSI is still a relatively unknown Nanotechnology company with proprietary technology,and a global partner in PPDI.
Market Cap 24M
Shares Outstanding: 6,985,863
Billion dollar Internation drug company
Pharmaceutical Product Development (NASDAQ PPDI)has equity stake in BDSI.
BioDelivery Science International, Inc
has a unique, patented delivery technology
with potential applications in the pharmaceutical,
OTC, nutraceutical, supplement, processed foods and
beverage industries. Its nanocochleate delivery
technology is made from all natural ingredients:
phosphatidylserine from soy and calcium. It is a simple,
safe, easy-to-manufacture, economical delivery technology.
The nanocochleates work by nano-encapsulating cargo molecules.
This is analogous to a “shrink-wrap” on a nano scale.
Once in the nanocochleates, the cargo molecules are
protected from heat, light, water,
enzymes, air, and pH. BDSI (www.biodeliverysciences.com)
is out-licensing this technology and using the
technology to develop its own pharmaceuticals.
9/15/2003
in Biodelivery SciencesInternational Inc. NASDAQ (BDSI) based on the recent successes of Nanotechnology companies (FLML, NANX, NVEC, TINY). BDSI is still a relatively unknown Nanotechnology company with proprietary technology,and a global partner in PPDI.
Market Cap 24M
Shares Outstanding: 6,985,863
Billion dollar Internation drug company
Pharmaceutical Product Development (NASDAQ PPDI)has equity stake in BDSI.
BioDelivery Science International, Inc
has a unique, patented delivery technology
with potential applications in the pharmaceutical,
OTC, nutraceutical, supplement, processed foods and
beverage industries. Its nanocochleate delivery
technology is made from all natural ingredients:
phosphatidylserine from soy and calcium. It is a simple,
safe, easy-to-manufacture, economical delivery technology.
The nanocochleates work by nano-encapsulating cargo molecules.
This is analogous to a “shrink-wrap” on a nano scale.
Once in the nanocochleates, the cargo molecules are
protected from heat, light, water,
enzymes, air, and pH. BDSI (www.biodeliverysciences.com)
is out-licensing this technology and using the
technology to develop its own pharmaceuticals.
9/15/2003
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
| Wertpapier | Perf. % |
|---|---|
| -1,09 | |
| -0,70 | |
| 0,00 | |
| -3,13 | |
| +10,00 | |
| -2,11 | |
| -0,20 | |
| -0,70 | |
| +2,05 | |
| 0,00 |
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 137 | ||
| 84 | ||
| 77 | ||
| 64 | ||
| 52 | ||
| 41 | ||
| 37 | ||
| 31 | ||
| 29 | ||
| 29 |
